APA (7th ed.) Citation

QA, B., RW, P., AM, B., 2nd, B. J., A, C., AL, C., . . . TP, T. (2024). Discovery of Pyrazolopyrazines as Selective, Potent, and Mutant-Active MET Inhibitors with Intracranial Efficacy. Journal of medicinal chemistry, 67(16), 14466. https://doi.org/10.1021/acs.jmedchem.4c01232

Chicago Style (17th ed.) Citation

QA, Bumpers, et al. "Discovery of Pyrazolopyrazines as Selective, Potent, and Mutant-Active MET Inhibitors with Intracranial Efficacy." Journal of Medicinal Chemistry 67, no. 16 (2024): 14466. https://doi.org/10.1021/acs.jmedchem.4c01232.

MLA (9th ed.) Citation

QA, Bumpers, et al. "Discovery of Pyrazolopyrazines as Selective, Potent, and Mutant-Active MET Inhibitors with Intracranial Efficacy." Journal of Medicinal Chemistry, vol. 67, no. 16, 2024, p. 14466, https://doi.org/10.1021/acs.jmedchem.4c01232.